Ameritox: National Public Health Emergency Declaration for Opioid Epidemic Important Step to Halting Crisis

COLUMBIA, Md., Oct. 26, 2017 /PRNewswire/ -- Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump. Ameritox has long advocated for dedication of additional attention and resources toward the opioid epidemic – the largest man-made epidemic in history.

"The patients Ameritox serves are not often connected to the opioid epidemic, in part because their clinicians utilize medication monitoring to help identify if a patient is headed down a dangerous path," said Todd Gardner, Chief Executive Officer of Ameritox. "This declaration will help equip all who are fighting the opioid epidemic with the additional tools they need to claim control – medication monitoring can and should be one of those tools," Gardner said. "Appropriate prescribing with monitoring and intervention can help stop the epidemic, and will improve clinical outcomes and lower costs."

Ameritox and Gardner recently sent a letter to the Chairman and Vice-Chairman of the United States House of Representatives Committee on Energy and Commerce in support of Jessie's Law, legislation aimed at spurring important conversations about opioid addiction among clinicians and patients, which was passed by the U.S. Senate and awaits action in the House. A copy of that letter can be viewed here: http://tinyurl.com/ameritox-letter

About Ameritox
Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse and diversion. As a trusted leader in medication monitoring, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Columbia, Md., has laboratory facilities in Greensboro, N.C.

Follow Ameritox on Twitter: www.twitter.com/ameritox 
Follow Ameritox on LinkedIn: www.linkedin.com/company/ameritox

Media Contact:

Genevieve Rozansky
202-509-0794
[email protected]

SOURCE Ameritox